Total Return Level Chart

View Total Return Level for UTHR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Return Level Chart
Start Trial

Historical Total Return Level Data

View and export this data back to 1999. Start Trial.
Date Value
September 15, 2026 500.35
September 14, 2026 502.70
September 11, 2026 497.11
September 10, 2026 503.86
September 09, 2026 506.82
September 08, 2026 497.97
September 04, 2026 487.61
September 03, 2026 490.24
September 02, 2026 492.02
September 01, 2026 512.70
August 31, 2026 510.38
August 28, 2026 515.46
August 27, 2026 527.91
August 26, 2026 516.68
August 25, 2026 518.53
August 24, 2026 512.88
August 21, 2026 513.12
August 20, 2026 521.00
August 19, 2026 529.14
August 18, 2026 518.27
August 17, 2026 508.48
August 14, 2026 499.73
August 13, 2026 501.27
August 12, 2026 511.72
August 11, 2026 515.50
Date Value
August 10, 2026 529.66
August 07, 2026 538.84
August 06, 2026 532.94
August 05, 2026 519.01
August 04, 2026 518.68
August 03, 2026 516.31
July 31, 2026 517.71
July 30, 2026 525.82
July 29, 2026 524.70
July 28, 2026 523.63
July 27, 2026 527.94
July 24, 2026 528.47
July 23, 2026 529.53
July 22, 2026 527.07
July 21, 2026 535.83
July 20, 2026 529.34
July 17, 2026 535.67
July 16, 2026 529.05
July 15, 2026 531.79
July 14, 2026 526.66
July 13, 2026 535.57
July 10, 2026 547.06
July 09, 2026 552.48
July 08, 2026 554.34
July 07, 2026 563.70

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Liquidia Corp. 65.72
MannKind Corp. 3.56
Vertex Pharmaceuticals, Inc. 514.63
Alnylam Pharmaceuticals, Inc. 238.27
Savara, Inc. 5.26